Nasdaq · Healthcare
iRhythm Holdings, Inc. (IRTC)
As-reported financials and recent SEC filings for iRhythm Holdings, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$747.1M
Net income
$-44.6M
Net margin
-6.0%
Diluted EPS
$-1.39
ROE
-29.2%
P/E (TTM)
—
Market cap
$3.91B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $747.1M | $591.8M | $492.7M | $410.9M | $322.8M |
| Gross profit | $527.3M | $407.5M | $331.8M | $281.6M | $213.6M |
| Operating income | $-57.4M | $-115.5M | $-125.2M | $-113.8M | $-99.9M |
| Net income | $-44.6M | $-113.3M | $-123.4M | $-116.2M | $-101.4M |
| Diluted EPS | $-1.39 | $-3.63 | $-4.04 | $-3.88 | $-3.46 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-15
View on EDGAR →8-K2026-06-05
View on EDGAR →42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →42026-06-01
View on EDGAR →42026-06-01
View on EDGAR →42026-06-01
View on EDGAR →42026-06-01
View on EDGAR →Go deeper on IRTC
Search iRhythm Holdings, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.